Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FUJRG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $29.7K delivery order (Contract No. 4569078039) by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with the federal government. The award was made without a set-aside designation, demonstrating the company's competitive standing in open federal procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA, valued at $499.999 billion and valid through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Entyvio is a specialty biologic medication used in the treatment of inflammatory bowel diseases, reflecting the vendor's role as a critical supplier of specialized pharmaceutical products to military health systems.
Quick answers
Who was awarded contract SPE2DB25FUJRG?
SPE2DB25FUJRG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FUJRG worth?
The government has obligated $29,670 on SPE2DB25FUJRG.
Is contract SPE2DB25FUJRG an order under another contract?
Yes. SPE2DB25FUJRG is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRG competed?
The extent of competition for SPE2DB25FUJRG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award